ARCHIVES

ACS Board Approves Special Donors Concept, Oks New Program or Cause And Prevention Research

This article is from The Cancer Letter archive.

Vol. 05 No. 08 | February 23, 1979

Download PDF Visit The Full Archive

Related Articles

Shorter, Simpler Consent Form Proposed For Phase I Trials

July 31, 2009

CMS Inserts Unprecedented Conditions Into Medicare Coverage of Lung Screening

November 14, 2014

Docetaxel As Adjuvant Therapy Shows Benefit Over Standard

June 28, 2002

Appeals Court Overturns FDA Approval Of Generic Paclitaxel, A Setback For Ivax.

November 9, 2001

Annual Report Key Element In Prevention Drive, Maquire Insists

February 2, 1979

In Brief: Deisseroth Leaves M.D. Anderson To Head Yale’s Oncology, Gene Therapy Programs

September 15, 1995